|
Hyphens Pharma International Limited is a specialty pharmaceutical and consumer healthcare group operating across Southeast Asia. The company is organized into three core business segments: Pharmaceutical and Medical Aesthetics, Proprietary Brands, and Digital Platform and E-Pharmacy. Its portfolio includes the flagship dermatological range Ceradan, the health supplement brand Ocean Health, and the acne treatment Winlevi. The group also manages the medical hypermart and digital pharmacy platform WellAway, alongside pharmaceutical distribution and retail operations under Pan-Malayan Pharmaceuticals. Key subsidiaries include Hyphens Pharma, DocMed Technology, Ocean Health, Novem Healthcare, and Ardence Aesthetics. The company serves markets in Singapore, Malaysia, Indonesia, Vietnam, and the Philippines, with extended reach into Thailand, Cambodia, Brunei, Bangladesh, Myanmar, Hong Kong, and Oman. Founded in 1988, the group focuses on developing and commercializing proprietary dermatological and health supplement products while distributing specialty pharmaceuticals. Summarised from the company's own disclosures, fiscal year ended Jun 2026 |
Industry Drug Manufacturers - General | Homepage hyphensgroup.com |
| Sector Healthcare | IR page hyphensgroup.com/investor-relations | |
|
Tags
specialty pharmaceuticals, dermatology, health supplements, medical aesthetics, e-pharmacy, pharmaceutical distribution, consumer healthcare, Ceradan, Ocean Health, Winlevi, WellAway, Pan-Malayan Pharmaceuticals, Hyphens Pharma, DocMed Technology, Novem Healthcare, Ardence Aesthetics, Visiopro, Cerapro MED
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | S$ 111.311M |
| P/E | 12.79 |
| P/BV | 1.66 |
| P/S | 0.57 |
| P/OCF | 30.66 |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | — |
| ROI | — |
| ROIC | — |
| Profit margin | — |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | No |
| Revenue up 3y | Yes |
| Revenue up 5y | No |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | -8.3% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpPrompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.